Characteristics of postjunctional carbamylcholine receptor activation and inhibition.
D000818:Animals; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D002217:Carbachol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002628:Chemoreceptor Cells / Q000187:drug effects*; D003472:Curare / Q000494:pharmacology; D004357:Drug Synergism; D005449:Fluorenes / Q000008:administration & dosage / Q000494:pharmacology; D066298:In Vitro Techniques; D007811:Lanthanum / Q000494:pharmacology; D008839:Microelectrodes; D009132:Muscles / Q000187:drug effects; D009467:Neuromuscular Depolarizing Agents; D010477:Perfusion; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D011894:Rana pipiens; D011950:Receptors, Cholinergic / Q000187:drug effects; D013977:Tibia; D014403:Tubocurarine / Q000008:administration & dosage / Q000494:pharmacology
D005449:Fluorenes; D009467:Neuromuscular Depolarizing Agents; D000644:Quaternary Ammonium Compounds; D011950:Receptors, Cholinergic; D007811:Lanthanum; D001285:Atropine; D003472:Curare; D002217:Carbachol; D014403:Tubocurarine